Bitfarms (NASDAQ:BITF) 株価情報

Bitfarms

Bitfarms Ltd engaged in the cryptocurrency Mining industry mainly consists of selling its computational power used for hashing calculations for cryptocurrency mining in multiple jurisdictions. Its geographic operations are currently located in Canada, the United States, Argentina. It owns and operates server farms comprised of computers designed to validate transactions on the Bitcoin Blockchain.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

News

Markets

$BTC

BITF

RIOT

最近、ビットコイン（仮想通貨：BTC）マイニング会社ライオットプラットフォーム（NASDAQ:RIOT）は、ライバル企業ビットファーム（NASDAQ:BITF）に対する持ち株比率を12%に引き上げました。

ライオットプラットフォームがビットファームの持ち株比率増加

Bitfarms Ltd

BitForex Token

BITFRONTIER CAPITAL HLDGS by BitFrontier Capital Holdings, Inc.

BitFrontier Capital Holdings Inc

BitFuFu Inc

Tango Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNGX#NASDAQ">TNGX</a>), a clinical-stage biotechnology company committed to discovering the next generation of precision cancer medicines, today announced that the first patient has been dosed in the TNG456 Phase 1/2 trial in patients with MTAP-deleted solid tumors, with a focus on glioblastoma (GBM). TNG456 is a next-generation, brain-penetrant, MTA-cooperative PRMT5 inhibitor.
The Phase 1/2 clinical trial (<a href="https://www.globenewswire.com/Tracker?data=JIMO_jzZSt6mqaqrqmYGz1o9qC54dwUMFXx4EoNCEgkGIBaAxZD_wiY81w6iF_dw-XXPZpoGu5fobSvjqOa7GYCwUjghjdQNuwzzbsV-ZzlEP1hGJnp_RiIBqVKXE9baSt7Pd2L09-motfFQGjJ55Q==">NCT06810544</a>) is evaluating the safety, pharmacokinetics, pharmacodynamics and antitumor activity of TNG456 as a monotherapy and in combination with abemaciclib. We are currently enrolling patients with TNG456 monotherapy in dose escalation focused on GBM.

TNGX

Tango Therapeutics Announces First Patient Dosed In TNG456 Phase 1/2 Trial In Patients With MTAP-Deleted Solid Tumors, With Focus On Glioblastoma

Needham analyst Bernie McTernan reiterates Wix.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WIX#NASDAQ">WIX</a>) with a Buy and maintains $250 price target.

Price Target

Reiteration

Analyst Ratings

Needham Reiterates Buy on Wix.com, Maintains $250 Price Target

Kevin O'Leary says the simplest path to millionaire status starts with one habit: siphon "15% of your income … and invest it in the index of the S&amp;P 500."
What Happened: The Shark Tank investor hit X with the prescription this week, insisting savers don't need to pick winners — or even "understand what a stock is" — to build real wealth.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The key to success on saving is to take 15% of your income when you&#39;re in your 20s and invest it in the index of the S&amp;P 500. You don&#39;t have to pick stocks and you don&#39;t even have to understand what a stock is, but over the period of your life, if you&#39;re taking that 15% every two… <a href="https://t.co/iuOQLaYE75">pic.twitter.com/iuOQLaYE75</a>
&mdash; Kevin O&#39;Leary aka Mr. Wonderful (@kevinolearytv) <a href="https://twitter.com/kevinolearytv/status/1924532379504542081?ref_src=twsrc%5Etfw">May 19, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
He doubled down on the math: "If you're taking that 15% every two weeks/month on an average salary, you'll end up a millionaire when you're 65 plus. … So it's about learning how to not buy sh&#x2A;t you don't need and investing that money instead." O'Leary framed the strategy as anti-debt armor, arguing index funds beat the temptation of ill-timed trades.
See also: <a href="https://www.benzinga.com/25/05/45513216/mark-cuban-took-a-chance-on-a-20-year-olds-cold-emailthat-350k-bet-helped-launch-a-46-billion-tech-giant">Mark Cuban Took A Chance On A 20-Year-Old&#8217;s Cold Email: That $350 Thousand Bet Helped Launch A $4.6 Billion Tech Giant</a>
Long-term data backs him up. The S&amp;P 500 has delivered more than a 10% annualized return since 1957, smoothing out crashes and recessions along the way, according to Investopedia <a href="https://www.investopedia.com/when-to-invest-in-sp-500-11735415">research</a>.
Personal-finance evangelist Dave Ramsey <a href="https://in.benzinga.com/personal-finance/25/03/44476778/author-says-dave-ramsey-is-completely-ignorant-of-sequence-of-returns-risk-questions-whether-1-million-is-really-enough-for-retirement">echoes the formula</a>, urging followers to "invest 15% of your income in tax-advantaged retirement accounts." Vanguard founder Jack Bogle spent decades <a href="https://www.benzinga.com/general/education/18/08/12290408/this-day-in-market-history-vanguard-launches-first-index-fund-for-u">preaching the same</a> low-cost gospel, while Warren Buffett told his own heirs to park 90% of their inheritance in a <a href="https://www.benzinga.com/markets/25/01/43388711/warren-buffett-believes-this-index-fund-is-the-best-option-for-everyday-investors">cheap S&amp;P tracker</a>.
That said, skeptics are abound. Personal-finance guru Robert Kiyosaki, earlier this week, <a href="https://x.com/theRealKiyosaki/status/1924170242609275368">dismissed index funds</a> and ETFs as mere "paper assets," urging investors to flee to hard assets like gold, silver and Bitcoin instead. According to a MarketWatch <a href="https://www.marketwatch.com/story/bill-ackman-actually-had-a-point-with-his-index-fund-bubble-theory-2016-01-30">article</a>, hedge-fund titan Bill Ackman likewise warned in his 2016 Pershing Square letter that massive inflows are inflating benchmark constituents and creating an "index-fund bubble." David Einhorn, on the other hand, says the dominance of passive strategies has "<a href="https://www.ft.com/content/260079a7-9b08-4dbd-909f-08c2407d1912">fundamentally broken</a>" market structure by siphoning capital from active managers and concentrating power in a few megacap stocks.
Photo Courtesy: Tada Images On Shutterstock.com
Read next: <a href="https://www.benzinga.com/25/05/45513154/trump-tariffs-triggered-price-surgeimports-hit-first-but-made-in-usa-goods-caught-in-the-crossfire-harvard-study-finds">Trump Tariffs Hit Imports For Sure, But Made In USA Purchases Also Didn&#8217;t Escape Price Rise Gauntlet, Shows Harvard Study</a>

Financial Advisors

Personal Finance

Kevin O'Leary Says This One Habit Alone Could Make You A Millionaire And You Don't Even Have To Bother Learning About Stocks

Accenture plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACN#NYSE">ACN</a>) disclosed on Tuesday that it is offering an <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/b45532971/accenture-collaborates-with-dell-technologies-and-nvidia-to-accelerate-enterprise-ai-transformatio" rel="noreferrer noopener">artificial intelligence solution</a> in partnership with Dell Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>) and NVIDIA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>).
This partnership expands the Accenture AI Refinery platform, enabling one-click deployment of agentic AI capabilities on Dell&#8217;s high-performance, NVIDIA-accelerated infrastructure.
This will help companies, particularly those within regulated industries or those with substantial investments in on-premises infrastructure, to accelerate value realization and reduce the total cost of ownership.
Also Read: <a target="_blank" href="https://www.benzinga.com/media/25/05/45484071/wall-streets-sugar-rush-bill-gates-on-tariffs-and-a-600-billion-saudi-deal-top-economics-updates-this-week" rel="noreferrer noopener">Wall Street&#8217;s &#8216;Sugar Rush,&#8217; Bill Gates On Tariffs And A $600 Billion Saudi Deal: Top Economics Updates</a>
Furthermore, Accenture will support AI implementation using the NVIDIA Enterprise AI Factory validated design, a framework for organizations to build on-premise AI factories utilizing NVIDIA Blackwell and a broad network of AI partners.
The company delivers on key needs: data sovereignty and compliance, resilience and high availability, robust security for isolated networks, ultra-low latency for real-time uses, and edge/offline capabilities for remote environments.
&#8220;Through this collaboration with Dell Technologies and NVIDIA, Accenture is bringing the power of AI Refinery to on-premises infrastructure, providing an open, interoperable, scalable, and secure solution that paves the way for widespread AI adoption,&#8221; said Lan Guan, chief AI officer, Accenture.
Ihab Tarazi, Chief Technical Officer and Senior Vice President of Dell Technologies, added, &#8220;This solution allows customers to tailor their strategies and engineered architectures to meet diverse needs, ensuring data integrity and protection to accelerate digital transformation.&#8221;
&#8220;Regulated industries face the unique challenge of harnessing AI to drive innovation and efficiency while rigorously adhering to complex compliance, data privacy, and governance standards,&#8221; said Justin Boitano, vice president of Enterprise AI Products, NVIDIA. &#8220;Together, NVIDIA, Accenture, and Dell deliver a turnkey AI platform for enterprises to accelerate transformation, unlock new value from data, and confidently scale AI in alignment with operational requirements.&#8221;
In a separate release, Accenture and&nbsp;SAP SE ADS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAP#NYSE">SAP</a>) disclosed the launch of ADVANCE, a joint initiative aimed at accelerating cloud adoption and business transformation for&nbsp;companies with annual <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/05/45527622/accenture-sap-launch-advance-to-boost-cloud-adoption-for-mid-sized-firms" rel="noreferrer noopener">revenue of up to $5 billion</a>.
Investors can gain exposure to ACN stock via Trust for Professional Managers Jensen Quality Growth ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JGRW#NYSE">JGRW</a>) and SMI 3Fourteen Full-Cycle Trend ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCTE#NASDAQ">FCTE</a>).
Price Action: Shares of Accenture, Dell, and NVIDIA were all trading lower in premarket at last check Wednesday, with ACN down 0.46% at $318.70, DELL down 1.22% at $112.84, and NVDA down 1.15% at $132.84.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/general/space/25/05/45430526/as-elon-musk-secures-saudi-starlink-deal-elizabeth-warren-and-senate-democrats-demand-probe-into-possible-ethics-violations-and-accuse-trump-administration-of-helping-spacex-secure-foreign-deals" target="_blank" rel="noreferrer noopener">As Elon Musk Secures Saudi Starlink Deal, Elizabeth Warren And Senate Democrats Demand Probe Into Possible Ethics Violations And Accuse Trump Administration Of Helping SpaceX Secure Foreign Deals</a></li>
</ul>
Image by AKOBCHUK V via Shutterstock

Equities

Large Cap

Tech

DELL

FCTE

Trust for Professional Managers Jensen Quality Growth ETF

JGRW

NVDA

Accenture, Dell, NVIDIA Deliver On-Premise AI Solution For Regulated Industries

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the financial sector.
<h3 class="wp-block-heading">AGNC Investment Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGNC#NASDAQ">AGNC</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 15.67%</li>
<li>RBC Capital analyst Kenneth Lee maintained an Outperform rating and lowered the price target from $11 to $10 on April 29, 2025. This analyst has an accuracy rate of 67%.</li>
<li>Argus Research analyst Kevin Heal reiterated a Hold rating on April 29, 2025. This analyst has an accuracy rate of 62%.</li>
<li>Recent News: On April 21, AGNC Investment posted upbeat quarterly earnings.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0521">latest AGNC news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0521"><img loading="lazy" decoding="async" width="902" height="831" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/21042700/image-260.png" alt="" class="wp-image-922406" style="width:614px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/21042700/image-260.png 902w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/21042700/image-260-300x276.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/21042700/image-260-768x708.png 768w" sizes="(max-width: 902px) 100vw, 902px" /></a></figure>
<h3 class="wp-block-heading">MFA Financial, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MFA#NYSE">MFA</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 14.52%</li>
<li>Keefe, Bruyette &amp; Woods analyst Bose George maintained an Outperform rating and cut the price target from $12.5 to $12 on May 8, 2025. This analyst has an accuracy rate of 72%.</li>
<li>Wedbush analyst Jay McCanless maintained an Outperform rating and raised the price target from $13 to $14 on Aug. 9, 2025. This analyst has an accuracy rate of 87%.</li>
<li>Recent News: On May 6, MFA Financial posted mixed quarterly results.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest MFA <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0521">news </a></li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0521"><img loading="lazy" decoding="async" width="902" height="822" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/21042730/image-261.png" alt="" class="wp-image-922407" style="width:587px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/21042730/image-261.png 902w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/21042730/image-261-300x273.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/21042730/image-261-768x700.png 768w" sizes="(max-width: 902px) 100vw, 902px" /></a></figure>
<h3 class="wp-block-heading">Annaly Capital Management, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NLY#NYSE">NLY</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 14.22%</li>
<li>Keefe, Bruyette &amp; Woods analyst Bose George maintained an Outperform rating and raised the price target from $20.15 to $20.5 on May 2, 2025. This analyst has an accuracy rate of 72%.</li>
<li>JP Morgan analyst Richard Shane maintained an Overweight rating and slashed the price target from $21 to $19 on April 16, 2025. This analyst has an accuracy rate of 68%.</li>
<li>Recent News: On April 30, Annaly Capital Management posted upbeat quarterly earnings.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0521">latest NLY news</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0521"><img loading="lazy" decoding="async" width="902" height="822" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/21042803/image-262.png" alt="" class="wp-image-922409" style="width:565px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/21042803/image-262.png 902w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/21042803/image-262-300x273.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/21042803/image-262-768x700.png 768w" sizes="(max-width: 902px) 100vw, 902px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More:
<ul class="wp-block-list">
<li> <a href="https://www.benzinga.com/25/05/45535402/target-lowes-and-3-stocks-to-watch-heading-into-wednesday">Target, Lowe&#8217;s And 3 Stocks To Watch Heading Into Wednesday</a> </li>
</ul>
Photo via Shutterstock

Dividends

Trading Ideas

AGNC

Wall Street's Most Accurate Analysts Weigh In On 3 Financial Stocks With Over 10% Dividend Yields

Purple Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PPBT#NASDAQ">PPBT</a>) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.06) by 183.33 percent. This is a 93.93 percent increase over losses of $(2.80) per share from the same period last year.

Earnings

Earnings Misses

PPBT

Purple Biotech Q1 EPS $(0.17) Misses $(0.06) Estimate

<a href="https://www.globenewswire.com/Tracker?data=Pmiif8Cl_kq7ts0rpuWWjwzbuqMZTNz8o1Oqr8EoImm_YPVnP91vEizqwi_P6nhL5UU8A3mmGGVAoQYRsHMHEiUQpF2kXpkFvQAjfuhFzKO-JCOirmdu1LU9r_MBmkTKWkBWR8DXC8RhwbeQxwzOuK8FB5w1uLS6yjjVWVfbHbKnT_ti5XxLoSYfpRBP5dOKfpdvjJt93-66WGQ54M8v8A==">Aduro Clean Technologies Inc.</a> ("Aduro" or the "Company") (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower-value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, today announced that it has engaged <a href="https://www.globenewswire.com/Tracker?data=rvYmSGASciNtf-ITvELjk-cBnw929gXAkxIGS43_UO3HW93tPLTDrlH7IbQ9bYF-vlPMSkIBN3miyS-rknwaZegc7kytm3RCf2iiloctNH_SZsUapqHlyBZna03KQcpY0Eh9JVPOWapy-2fobugI80IuWXepnAxuiuIGoQ7Xk6s=">Delphi</a>, a leading Canadian sustainability consultancy, to conduct a Life Cycle Assessment ("LCA") of the Company's Hydrochemolytic&#x2122; technology for waste plastic processing.
Delphi is a strategic consulting firm with 35 years of experience, specializing in corporate sustainability, climate change, the green economy, and cleantech innovation. The LCA is part of Aduro's strategic roadmap to independently assess and quantify the environmental performance of its chemical recycling platform through a phased, data-driven process. With increasing regulatory and market emphasis on measurable environmental outcomes, the LCA provides a foundation for engaging stakeholders with credible, third party-reviewed information. Additionally, the LCA will provide critical data to assist in identifying and minimizing inefficiencies and energy consumption throughout the process, assisting in maximizing resource efficiency and reducing operational costs.
The project will begin with a screening-level LCA focused on greenhouse gas ("GHG") emissions and energy use, associated with operating the Hydrochemolytic&#x2122; technology process. This assessment, based on pre-pilot-scale performance data and forward-looking design parameters, will follow <a href="https://www.globenewswire.com/Tracker?data=D2byHyj0nOkdqQZ04onCVjrDzFO09aPWyvQVrtaz3AJAi_Uiu-UlK3g6_ZnAmUstqf8DbQ6z5PP7e0kQmRTF5qmeXa66RyKs8LITnq6f_6WfCrHnTFqsC0Lr57J_22rk">ISO 14040</a> and 14044 frameworks to provide directional insights into the technology's environmental profile. This phase will lay the groundwork for future work as more detailed data becomes available. The screening assessment will support Aduro's broader efforts to align its innovation strategy with the performance expectations of regulators, customers, and investors in the circular economy.
Subsequent phases of the LCA will incorporate operational data from the Company's Next Generation Process ("NGP") pilot plant, which is currently under construction. The second phase will provide a more comprehensive, ISO-compliant assessment of all relevant life cycle stages, including feedstock sourcing and downstream product pathways. A final phase is anticipated to support a comparative LCA, benchmarking the Hydrochemolytic&#x2122; process against other chemical recycling approaches.

ADUR

Aduro Clean Technologies Engages Delphi To Conduct Life Cycle Assessment Of Hydrochemolytic Technology For Waste Plastic Processing

Jefferies analyst David Chiaverini initiates coverage on Fifth Third Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FITB#NASDAQ">FITB</a>) with a Buy rating and announces Price Target of $47.

Initiation

FITB

Jefferies Initiates Coverage On Fifth Third Bancorp with Buy Rating, Announces Price Target of $47

The Addition of Physical Copper to the Sprott Copper Miners ETF (COPP) Will Make COPP the Only1 ETF to Provide Investment Exposure to Physical Copper
TORONTO, May 21, 2025 (GLOBE NEWSWIRE) -- &nbsp;Sprott Asset Management USA, Inc. today announced that, effective June 23, 2025, the Sprott Copper Miners ETF (COPP) will include an allocation to physical copper. This change will make COPP the only1 ETF to provide exposure to physical copper and the only1&nbsp;ETF to provide pure-play2&nbsp;exposure to large-, mid- and small-cap copper miners.
The change will result from a modification to the Sprott Copper Miners ETF's underlying index, the Nasdaq Sprott Copper MinersTM Index (NSCOPPTM). At its scheduled June semi-annual rebalance, effective at the market open on June 23, the index will add a 4.75% allocation to physical copper via the inclusion of the Sprott Physical Copper Trust, the world's first and only physical copper investment fund.

Sprott Asset Management USA Says Sprott Copper Miners ETF Will Include Allocation To Physical Copper, Effective June 23, 2025

HC Wainwright &amp; Co. analyst Patrick Trucchio reiterates Oncolytics Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONCY#NASDAQ">ONCY</a>) with a Buy and maintains $5 price target.

ONCY

HC Wainwright & Co. Reiterates Buy on Oncolytics Biotech, Maintains $5 Price Target

MRNA

Moderna Announced That In Consultation With The U.S. Food And Drug Administration, The Company Has Voluntarily Withdrawn The Pending Biologics License Application For Mrna-1083, Its Flu/Covid Combination Vaccine Candidate For Adults Aged 50 Years And Older

Epic Games&#8216; popular battle royale game &#8220;Fortnite&#8221; has returned to Apple Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) App Store in the United States after a nearly five-year absence, marking a significant shift in the mobile app ecosystem following a federal court ruling against Apple&#8217;s payment practices.
What Happened: Fortnite became available again on Apple&#8217;s iOS systems in the U.S. on Tuesday, ending a ban that began in 2020 when Apple removed the game from its platform amid a dispute over in-app payment commissions, as reported by Reuters. 
The return follows an April 30 ruling by a federal judge stating that Apple violated a U.S. court order requiring the company to allow greater competition for app downloads and payment methods.
Epic Games CEO Tim Sweeney celebrated the return on social media platform X, posting &#8220;We back fam.&#8221; Sweeney has also <a href="https://www.benzinga.com/news/legal/25/04/45123864/apple-ordered-to-ease-app-store-rules-in-us-epic-games-ceo-tim-sweeney-proposes-peace-deal-saying-well-return-fortnite-and-drop-all-litigation-only-if">proposed a peace deal</a>, offering to return Fortnite to the App Store worldwide and abandon all litigation if Apple relaxes its App Store rules globally. He revealed that battling Apple over the past five years has cost Epic Games over $1 billion, but he believes it was worth it.
See Also: <a href="https://www.benzinga.com/government/regulations/25/05/45537919/fda-limits-annual-covid-19-boosters-to-high-risk-americans-demands-new-trials-for-healthy-adults-in-policy-shift-under-rfk-jr">FDA Limits Annual COVID-19 Boosters To High-Risk Americans, Demands New Trials For Healthy Adults In Policy Shift Under RFK Jr.</a>
Why It Matters: Apple has expressed apprehension over the potential financial consequences of the contempt ruling, warning it could lead to &#8220;substantial&#8221; financial losses estimated at <a href="https://www.benzinga.com/markets/equities/25/05/45277610/apple-warns-of-hundreds-of-millions-to-billions-dollar-losses-over-epic-games-ruling-seeks-stay-amid-app-store-shakeup">&#8220;hundreds of millions to billions&#8221;</a> of dollars annually.
The decision effectively prevents Apple from charging its usual commission of up to 30% on in-app payments for developers who direct users to alternative payment methods.
For Epic Games, this victory comes after a lengthy legal battle that began in 2020 when both Apple and Alphabet Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) Google banned Fortnite from their stores over in-app payment disputes. The game had already returned to Android devices worldwide and iPhones in the European Union last year.
Image Via Shutterstock
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/global/25/05/45537805/musks-starlink-could-sidestep-south-african-equity-rules-under-deal-aimed-at-calming-relations-ahead-of-trump-meeting-report">Musk&#8217;s Starlink Could Sidestep South African Equity Rules Under Deal Aimed At Calming Relations Ahead Of Trump Meeting: Report</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Gaming

Regulations

AAPL

GOOG

GOOGL

NFLX

SPOT

Fortnite Storms Back To iPhones After 5‑Year Ban As Court Ruling Undercuts Apple's 30% App‑Store Toll

Jefferies analyst David Chiaverini initiates coverage on M&amp;T Bank (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTB#NYSE">MTB</a>) with a Buy rating and announces Price Target of $225.

Jefferies Initiates Coverage On M&T Bank with Buy Rating, Announces Price Target of $225

The Company demonstrated strong mucoadhesion and broad surface coverage in ex vivo nasal tissue models
Raanana, Israel, May 21, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRZ#NASDAQ">PLRZ</a>) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced compelling results from recent ex vivo studies demonstrating the mucoadhesive strength and extensive nasal surface coverage of its proprietary formulation platform.
The studies were conducted in collaboration with Prof. Fabio Sonvico's laboratory, utilizing excised rabbit nasal mucosa as a surrogate for human nasal tissues. The research aimed to characterize two key technological aspects of Polyrizon's formulation: surface coverage capability and mucoadhesive performance, both essential properties for protection against airborne biological assaults and for effective intranasal therapeutic delivery.
Advanced ex vivo studies using two-photon fluorescence microscopy demonstrated that Polyrizon's formulation spreads rapidly and uniformly across the nasal mucosa, forming a consistent surface layer. The use of fluorescent markers confirmed that the formulation was accurately localized on the tissue, clearly distinguishable from natural tissue autofluorescence. This broad and uniform coverage is essential for ensuring effective localized protection or drug delivery. In parallel, mucoadhesion testing showed that the formulation maintains a strong and lasting attachment to the nasal tissue, even under conditions simulating physiological nasal fluid flow. This prolonged retention supports the potential for extended efficacy and enhances the potential for therapeutic benefit by helping the formulation stay in place long enough to exert its intended effect.

PLRZ

Polyrizon Announces Results From Recent Ex Vivo Studies Demonstrating Mucoadhesive Strength And Extensive Nasal Surface Coverage Of Its Proprietary Formulation Platform

New program enables issuers to enhance commercial offerings through fully integrated digital solutions
Visa (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>), a global leader in digital payments, announced Visa Commercial Integrated Partners, a new program designed to improve connectivity between fintechs and Visa Commercial products through its commercial platform. Visa will make available advanced APIs to embed Visa products in a business partners' applications and make these integrations available to its financial institution clients, allowing them to offer new, seamless payment experiences to their business customers.

Visa Announces Visa Commercial Integrated Partners, New Program To Improve Connectivity Between Fintechs And Visa Commercial Products Through Its Commercial Platform

Magic Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGIC#NASDAQ">MGIC</a>) reported quarterly earnings of $0.25 per share which met the analyst consensus estimate. This is a 8.7 percent increase over earnings of $0.23 per share from the same period last year. The company reported quarterly sales of $147.30 million which beat the analyst consensus estimate of $143.79 million by 2.44 percent. This is a 12.68 percent increase over sales of $130.72 million the same period last year.

Earnings Beats

MGIC

Magic Software Q1 Adj. EPS $0.25, Inline, Sales $147.30M Beat $143.79M Estimate

Cryptocurrency markets are stable on Wednesday morning, with Bitcoin retreating to $106,000 after tapping $108,000 during Asia trading hours.
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>$106,244.58</td>
<td>+0.95%</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>$2,519.57</td>
<td>+0.13%</td>
</tr>
<tr>
<td>Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td>$168.03</td>
<td>+0.7%</td>
</tr>
<tr>
<td>XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td>$2.33</td>
<td>-0.6%</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>$0.2251</td>
<td>+1.9%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>$0.00001443</td>
<td>+1.1%</td>
</tr>
</tbody>
</table>
</figure>
Notable Statistics:
<ul class="wp-block-list">
<li>IntoTheBlock data shows Bitcoin and Ethereum daily active addresses increased by 5.5% and 6.4%, respectively. BTC's large transaction volume went up by 10%.</li>
<li>Coinglass data shows 90,882 traders were liquidated in the past 24 hours for $257.09 million.</li>
<li>SoSoValue data shows $329 million in net inflows into spot Bitcoin ETFs and $64.9 million net inflows into spot Ethereum ETFs. </li>
</ul>
Trader Notes: Nic Puckrin, co-founder of CoinBureau, noted a wave of limit orders above $107,500 caused a sharp rejection at $108,000. He warned that the road to new all-time highs would remain volatile.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Lots of limit orders above $107.5k hit which led to a hard rejection at $108k. The route to all-time-highs is going to be choppy &#x1f440; <a href="https://t.co/2r29qOMjxm">pic.twitter.com/2r29qOMjxm</a>
&mdash; Nic (@nicrypto) <a href="https://twitter.com/nicrypto/status/1925105899963633666?ref_src=twsrc%5Etfw">May 21, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
CoinBureau also <a href="https://x.com/coinbureau/status/1925083657103868162">highlighted</a> that $1.01 billion in short positions are set to be liquidated at $108,000. If triggered, these shorts could fuel a rapid BTC surge as bears are forced to buy back into the market.
Dogecoin continues to defy broader market inertia. Javon Marks compared the current cycle to previous bull runs and projected a 215% rally, taking DOGE to a minimum of $0.73905.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">By Dogecoin&#39;s previous bull cycles and its similar setup this cycle, another nearly +215% increase to $0.73905, AT THE MINIMUM, can be on the way &#x26a1;&#xFE0F;.<a href="https://twitter.com/search?q=%24DOGE&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$DOGE</a> <a href="https://t.co/0CQt5EPADZ">pic.twitter.com/0CQt5EPADZ</a>
&mdash; JAVON&#x26a1;&#xFE0F;MARKS (@JavonTM1) <a href="https://twitter.com/JavonTM1/status/1925025654963073215?ref_src=twsrc%5Etfw">May 21, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
IncomeSharks <a href="https://x.com/IncomeSharks/status/1924931752252080327">remains</a> bullish on Ethereum, sticking to a $3,000 target—and even eyeing $4,000, provided the $2,515 support holds. He admitted his only regret is not being more bullish on ETH earlier.
Crypto Bitlord made a bold <a href="https://x.com/crypto_bitlord7/status/1925104825114755164">prediction</a>: "If Bitcoin hits $400,000, then XRP at $80 becomes not just possible, but easy." He dismissed ETH and Solana as "too safe," suggesting they won't produce the generational wealth this cycle could offer.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45525006/bitcoin-is-about-to-make-a-golden-cross-what-happens-next">Bitcoin Is About To Make A Golden Cross: What Happens Next?</a></li>
</ul>

$DOGE

$ETH

$SHIB

$SOL

$XRP

Bitcoin, Dogecoin Green But XRP Struggling On Wednesday Morning

Investigator-initiated Phase 2 trial to evaluate TNX-102 SL's potential to reduce severity of acute stress reaction (ASR) and frequency of acute stress disorder (ASD)
Trial is sponsored by the University of North Carolina (UNC) and supported by a grant from the U.S. Department of Defense
Topline results from the trial are expected in the second half of 2026
CHATHAM, N.J., May 21, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNXP#NASDAQ">TNXP</a>), a fully-integrated biotechnology company with marketed products and a pipeline of development candidates, today announced the first patient has been dosed in the Phase 2, investigator-initiated OASIS trial to evaluate TNX-102 SL in reducing the severity of acute stress reaction (ASR) and the frequency of acute stress disorder (ASD). The trial is sponsored by the University of North Carolina (UNC) Institute for Trauma Recovery and supported by a $3 million grant from the U.S. Department of Defense (DoD).
The Optimizing Acute Stress Reaction Interventions with TNX-102 SL (OASIS) trial will examine the safety and efficacy of TNX-102 SL to reduce adverse posttraumatic neuropsychiatric sequelae among patients presenting to the emergency department (ED) after a motor vehicle collision (MVC). The trial plans to enroll approximately 180 MVC-trauma survivors at ED study sites around the U.S. Participants will be randomized in the ED to receive a two-week course of either TNX-102 SL 5.6 mg or placebo.
The OASIS trial will build upon a foundation of knowledge and infrastructure developed through the UNC-led, $40 million AURORA initiative. AURORA is a major national research initiative to improve the understanding, prevention and recovery of individuals who experience a traumatic event. AURORA is supported by funding from the National Institutes of Health (NIH), leading brain health nonprofit One Mind, private foundations, and partnerships with leading tech companies, such as Mindstrong Health and Verily Life Sciences, the healthcare arm of Alphabet, the parent company of Google.
Acute and chronic stress disorders can affect both civilian and military populations. According to the National Center for PTSD, in the U.S. about 60% of men and 50% of women experience at least one trauma in their lives In the U.S. alone, one-third of ED visits (40-50 million patients per year) involve evaluation after trauma exposures, and in a 2014 study involving 3,157 US veterans, 87% reported exposure to at least one potentially traumatic event during their service. Moreover, as many as 500,000 U.S. troops who served in wars between 2001 and 2015 were diagnosed with PTSD. Currently, no medication is available in the immediate aftermath of traumatic events to treat the initial reaction and support long term health via a post-trauma clinical trajectory that prevents development or worsening of ASD, thereby also preventing PTSD.

TNXP

Tonix Pharma Announces First Patient Dosed In Phase 2, Investigator-Initiated OASIS Trial To Evaluate TNX-102 SL In Reducing Severity Of ASR And Frequency Of ASD

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">B&amp;G Foods Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BGS#NYSE">BGS</a>)</h3>
<ul class="wp-block-list">
<li>On May 7, B&amp;G Foods reported worse-than-expected first-quarter financial results and cut its FY25 adjusted EPS guidance below estimates. Also, the company cut its FY25 sales guidance. Casey Keller, President and Chief Executive Officer of B&amp;G Foods, said, &#8220;Our first quarter results reflect the challenging environment in the packaged foods industry at the start of 2025, including the impact of retailer inventory reductions and a shift in Easter timing into the second quarter. While January and February were especially difficult, recent net sales in March, April and early May have begun to show stabilizing trends versus last year.&#8221; The company's stock fell around 38% over the past month and has a 52-week low of $4.06.</li>
<li>RSI Value: 21.5</li>
<li>BGS Price Action: Shares of B&amp;G Foods fell 4.5% to close at $4.21 on Tuesday.</li>
<li>Edge Stock Ratings: 10.18 Momentum score with Value at 41.61. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/quote/BGS"><img loading="lazy" decoding="async" width="473" height="175" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/21035653/image-256.png" alt="" class="wp-image-922355" style="width:343px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/21035653/image-256.png 473w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/21035653/image-256-300x111.png 300w" sizes="(max-width: 473px) 100vw, 473px" /></a></figure>
<h3 class="wp-block-heading">Forafric Global PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRI#NASDAQ">AFRI</a>)&nbsp;&nbsp;&nbsp;</h3>
<ul class="wp-block-list">
<li>On April 4, Forafric Global named CEO Khalid Assari as Chairman of Board, replacing Saad Bendidi. &#8220;I am honored to take on the role of Chairman and look forward to working closely with the Board and leadership team to advance Forafric Global&#8217;s mission and strategic goals,&#8221; said Mr. Assari. The company's stock fell around 9% over the past month and <a href="https://www.benzinga.com/quote/AFRI">has a 52-week low</a> of $7.54.</li>
<li>RSI Value: 15.6</li>
<li>AFRI Price Action: Shares of Forafric Global fell 0.1% to close at $7.78 on Tuesday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend in <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0521">AFRI stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0521"><img loading="lazy" decoding="async" width="916" height="822" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/21035802/image-257.png" alt="" class="wp-image-922356" style="width:584px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/21035802/image-257.png 916w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/21035802/image-257-300x269.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/21035802/image-257-768x689.png 768w" sizes="(max-width: 916px) 100vw, 916px" /></a></figure>
<h3 class="wp-block-heading">Paranovus Entertainment Technology Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAVS#NASDAQ">PAVS</a>)</h3>
<ul class="wp-block-list">
<li>On April 29, Paranovus Entertainment Technology said it regained Nasdaq compliance. The company's stock fell around 26% over the past month and has a 52-week <a href="https://www.benzinga.com/quote/PAVS">low of $0.32</a>.</li>
<li>RSI Value: 28.4</li>
<li>PAVS Price Action: Shares of Paranovus Entertainment Technology fell 3% to close at $0.98 on Tuesday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential breakout in <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0521">PAVS shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0521"><img loading="lazy" decoding="async" width="875" height="823" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/21035851/image-258.png" alt="" class="wp-image-922357" style="width:565px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/21035851/image-258.png 875w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/21035851/image-258-300x282.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/21035851/image-258-768x722.png 768w" sizes="(max-width: 875px) 100vw, 875px" /></a></figure>
Learn more about BZ Edge Rankings—click to see scores for other stocks in the sector and s<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">ee how they compare.</a> 
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45535402/target-lowes-and-3-stocks-to-watch-heading-into-wednesday">Target, Lowe&#8217;s And 3 Stocks To Watch Heading Into Wednesday</a> </li>
</ul>
Photo via Shutterstock

Long Ideas

Pre-Market Outlook

AFRI

PAVS

Top 3 Defensive Stocks That Are Preparing To Pump This Month

FEAM

5E Advanced Material Announced That It Has Achieved Another Developmental Milestone, Completing Equipment Testing For All Major Processes Of The Commercial Design For Its Large-scale Boron Facility

Legal

Press Releases

Shareholders who lost money investing in Bitfarms Ltd.  (BITF) Should Contact Wolf Haldenstein

Levi & Korsinsky Reminds Bitfarms Ltd. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 8, 2025 – BITF

BITF Class Action Alert: Robbins LLP Reminds Bitfarms, Ltd. Stockholders of the Pending Lead Plaintiff Deadline of July 8, 2025

The Gross Law Firm Notifies Bitfarms Ltd. Investors of a Class Action Lawsuit and Upcoming Deadline - BITF

ROSEN, A TOP RANKED LAW FIRM, Encourages Bitfarms Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BITF

Investors in Bitfarms Ltd. Should Contact Levi & Korsinsky Before July 8, 2025 to Discuss Your Rights - BITF

Pomerantz Law Firm Announces the Filing of a Class Action Against Bitfarms Ltd. and Certain Officers - BITF

Penny Stocks

Small Cap

BITF Investors Have Opportunity to Lead Bitfarms Ltd. Securities Fraud Lawsuit with the Schall Law Firm

BITF Investor Notice: Robbins LLP Reminds Stockholders of the Securities Class Action Against Bitfarms Ltd.

BITF Investors Have Opportunity to Lead Bitfarms Ltd. Securities Fraud Lawsuit

HC Wainwright & Co.

Alliance Global Partners

Cantor Fitzgerald

B. Riley Securities

Untitled design - 2024-08-30T174008.310

FUFU

BitFuFu Posts 70% Revenue Growth And Outlines Strategic Expansion – Company Expects Continued Growth Amid Market Volatility

wind-energy-7394705_1920

TSLA

EcoAI Coin: Leading The Charge Towards Sustainable Cryptocurrency Practices

Screenshot 2024-05-29 at 5.42.06 PM

CLSK

MARA

BitFuFu Q1 Earnings: Adjusted EBITDA Up 430.9% To $49.4 Million On Revenue Growth Of 149%, Cash Position Rises To $163.7 Million

Comments

Bitfarms

ニュース

パートナーシップ

ベンジンガ・グローバル